immune checkpoint inhibitors: interaction between pd-1 and pd-l1 blocked by therapeutic antibodies

antibody blockade cancer cell checkpoint death immune immunotherapy inhibition inhibitor membrane oncology pd1 pdl1 programmed protein receptor surface system tcell tlymphocyte tumor